Aipore
Latest round
- Series B
Last raised
- Jul 2023
Total raised
- $3.7M
Investors
- 2
About Aipore
Founded in 2018 in Tokyo, Japan, Aipore Inc. is dedicated to developing cutting-edge measurement solutions.Aipore focuses on advanced particle measurement technology, specifically targeting viruses, bacteria, and exosomes through its innovative AI-driven solutions. Their core product offerings include a highly precise pore sensor module and a microparticle measurement device that leverage semiconductor microfabrication to achieve superior measurement stability and accuracy beyond conventional nanopore methods. These technologies enable real-time identification of various viral strains and bacterial subtypes, along with determining viability and estimating the origins of exosomes. Released in 2020, their research and development solutions cater to a diverse clientele across multiple sectors including healthcare, diagnostics, and environmental monitoring.Aipore generates revenue through various direct sales channels, including partnerships and collaborations with research institutions, diagnostics companies, and other enterprises requiring advanced particle measurement capabilities. The transactional structure often involves direct sales of their flagship products, such as their pore sensor module and associated AI identification systems, to B2B clients, which may include laboratories and healthcare providers. Clients typically engage in one-time purchases or may explore ongoing partnerships for technology integration and support. The revenue model is further enhanced by potential subscription-based services for software updates and technical support, ensuring continual engagement with their client base.In July 2023, Aipore Inc. The investment will be utilized to accelerate the development of testing products for point-of-care testing (POCT) and to increase the variation of testing products. Aipore's strategy includes plans to expand its market presence by targeting new regions and sectors, although specific markets for future expansion have not been disclosed.
Who invested in Aipore
2 investors across 2 rounds
See all investors in Aipore
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Aipore
Who invested in Aipore?
Aipore has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Aipore raised?
Aipore has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Aipore last raise money?
Aipore's most recent round on record is a Series B, in Jul 2023.
What does Aipore do?
Founded in 2018 in Tokyo, Japan, Aipore Inc.
Where is Aipore headquartered?
Aipore is headquartered in Tokyo, Japan.
Which VCs invest in companies like Aipore?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back medical devices & equipment companies at Aipore's stage. Their profiles are linked below.
VCs backing medical devices & equipment startups at Series B
Raising like Aipore? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.